These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15701627

  • 1. Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.
    Horton JK, Stefanick DF, Naron JM, Kedar PS, Wilson SH.
    J Biol Chem; 2005 Apr 22; 280(16):15773-85. PubMed ID: 15701627
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
    Horton JK, Stefanick DF, Gassman NR, Williams JG, Gabel SA, Cuneo MJ, Prasad R, Kedar PS, Derose EF, Hou EW, London RE, Wilson SH.
    DNA Repair (Amst); 2013 Sep 22; 12(9):774-85. PubMed ID: 23871146
    [Abstract] [Full Text] [Related]

  • 4. Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.
    Heacock ML, Stefanick DF, Horton JK, Wilson SH.
    DNA Repair (Amst); 2010 Aug 05; 9(8):929-36. PubMed ID: 20573551
    [Abstract] [Full Text] [Related]

  • 5. ATR signaling mediates an S-phase checkpoint after inhibition of poly(ADP-ribose) polymerase activity.
    Horton JK, Stefanick DF, Kedar PS, Wilson SH.
    DNA Repair (Amst); 2007 Jun 01; 6(6):742-50. PubMed ID: 17292679
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
    Noël G, Godon C, Fernet M, Giocanti N, Mégnin-Chanet F, Favaudon V.
    Mol Cancer Ther; 2006 Mar 01; 5(3):564-74. PubMed ID: 16546970
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE, Helleday T.
    Nucleic Acids Res; 2006 Mar 01; 34(6):1685-91. PubMed ID: 16556909
    [Abstract] [Full Text] [Related]

  • 9. Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition.
    Kedar PS, Stefanick DF, Horton JK, Wilson SH.
    DNA Repair (Amst); 2008 Nov 01; 7(11):1787-98. PubMed ID: 18691676
    [Abstract] [Full Text] [Related]

  • 10. Involvement of poly(ADP-ribose) polymerase activity in regulating Chk1-dependent apoptotic cell death.
    Horton JK, Stefanick DF, Wilson SH.
    DNA Repair (Amst); 2005 Sep 28; 4(10):1111-20. PubMed ID: 16002346
    [Abstract] [Full Text] [Related]

  • 11. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
    Schlicker A, Peschke P, Bürkle A, Hahn EW, Kim JH.
    Int J Radiat Biol; 1999 Jan 28; 75(1):91-100. PubMed ID: 9972795
    [Abstract] [Full Text] [Related]

  • 12. Predicting enhanced cell killing through PARP inhibition.
    Horton JK, Wilson SH.
    Mol Cancer Res; 2013 Jan 28; 11(1):13-8. PubMed ID: 23193155
    [Abstract] [Full Text] [Related]

  • 13. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.
    Löser DA, Shibata A, Shibata AK, Woodbine LJ, Jeggo PA, Chalmers AJ.
    Mol Cancer Ther; 2010 Jun 28; 9(6):1775-87. PubMed ID: 20530711
    [Abstract] [Full Text] [Related]

  • 14. A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1.
    Lu HR, Wang X, Wang Y.
    Cell Cycle; 2006 Oct 28; 5(20):2364-70. PubMed ID: 17102615
    [Abstract] [Full Text] [Related]

  • 15. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Luo Q, Li Y, Deng J, Zhang Z.
    Chem Biol Interact; 2015 Jan 25; 226():12-22. PubMed ID: 25499136
    [Abstract] [Full Text] [Related]

  • 16. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    Luo Q, Li Y, Lai Y, Zhang Z.
    J Toxicol Sci; 2015 Jun 25; 40(3):349-63. PubMed ID: 25972196
    [Abstract] [Full Text] [Related]

  • 17. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
    Muñoz-Gámez JA, Martín-Oliva D, Aguilar-Quesada R, Cañuelo A, Nuñez MI, Valenzuela MT, Ruiz de Almodóvar JM, De Murcia G, Oliver FJ.
    Biochem J; 2005 Feb 15; 386(Pt 1):119-25. PubMed ID: 15456408
    [Abstract] [Full Text] [Related]

  • 18. Hyperactivation of PARP triggers nonhomologous end-joining in repair-deficient mouse fibroblasts.
    Gassman NR, Stefanick DF, Kedar PS, Horton JK, Wilson SH.
    PLoS One; 2012 Feb 15; 7(11):e49301. PubMed ID: 23145148
    [Abstract] [Full Text] [Related]

  • 19. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A, Kurokawa S, Takehashi M, Maeda A, Fukuda K, Kubo Y, Nogusa H, Takatani-Nakase T, Okuda S, Ueda K, Tanaka S.
    BMC Neurosci; 2017 Jan 17; 18(1):14. PubMed ID: 28095779
    [Abstract] [Full Text] [Related]

  • 20. DNA polymerase β-dependent cell survival independent of XRCC1 expression.
    Horton JK, Gassman NR, Dunigan BD, Stefanick DF, Wilson SH.
    DNA Repair (Amst); 2015 Feb 17; 26():23-9. PubMed ID: 25541391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.